phone icon (917) 310-3371 Explore Zepbound Menu
Nao Medical Logo

Zepbound weight loss in NYC and Long Island

Use the main weight-loss overview as the broad parent guidance, then move through the branded Zepbound treatment path for coverage, self-pay workflow, availability, and comparison against Wegovy.

Nao Medical offers provider-guided Zepbound evaluation across NYC and Long Island, including coverage review, self-pay workflow planning, pharmacy-availability troubleshooting, and branded comparison against Wegovy when patients ask by medication name.

Zepbound is reviewed for adults with obesity, or adults with overweight plus at least one weight-related medical condition, alongside a reduced-calorie diet and increased physical activity. FDA also approved Zepbound for some adults with moderate to severe obstructive sleep apnea and obesity. The actual decision still depends on medical history, GI tolerance, current medications, thyroid-cancer risk factors, pregnancy planning, and whether another GLP-1 path fits better.

Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Zepbound prescription coverage is separate from visit coverage and often depends on obesity-drug exclusions, prior authorization rules, employer carve-outs, and the pharmacy benefit.

Answer the branded medication question directly Patients asking about Zepbound usually need direct answers about coverage, self-pay workflow, fulfillment, and how it compares with Wegovy.

What Zepbound care should cover clarify first

Nao Medical offers provider-guided Zepbound evaluation across NYC and Long Island, including coverage review, self-pay workflow planning, pharmacy-availability troubleshooting, and branded comparison against Wegovy when patients ask by medication name.

What makes Zepbound different

Patients asking about a brand-name option usually need access, coverage, and pharmacy guidance in addition to general GLP-1 education.

What the first visit should separate

The visit, the prescription, the prior-authorization path, the self-pay fallback, and the refill plan are different decisions. A good program explains each one clearly.

What the safety review still needs to cover

Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or other GLP-1 agonists. Personal or family history of medullary thyroid carcinoma or MEN2, pancreatitis questions, gallbladder symptoms, kidney issues, planned surgery, pregnancy planning, and severe GI symptoms all need review first.

Why the branded comparison matters

Zepbound and Wegovy are both once-weekly branded obesity medications, but Zepbound uses tirzepatide (GIP plus GLP-1) while Wegovy uses semaglutide (GLP-1 only). Lilly's SURMOUNT-5 results showed higher average weight loss with Zepbound than Wegovy at 72 weeks, but the better fit still depends on coverage, tolerability, refill stability, and whether the patient is already doing well on Wegovy.

Zepbound questions patients usually need answered next

Insurance

Use the insurance guidance when prior authorization, exclusions, savings rules, or plan design are the real question.

Self-pay workflow

Use the self-pay guidance when the patient wants to move without waiting on coverage and needs the operational steps mapped out clearly.

Availability

Use the availability guidance when the real friction is dose fulfillment, refill timing, or channel stability.

Zepbound vs Wegovy

Use the comparison guide when the patient already knows the decision is between the two leading branded obesity medications.

Locations that support Zepbound-related weight-loss visits

These existing weight-loss clinic details are the practical next step when patients want an in-person path for GLP-1 evaluation, coverage review, refill support, and long-term follow-up close to home.

174th Street Zepbound support location

Bronx

174th Street

932 E 174th St, Bronx, NY 10460

A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.

View weight-loss location Get directions
Astoria Zepbound support location

Queens

Astoria

37-15 23rd Ave, Astoria, NY 11105

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.

View weight-loss location Get directions
Bartow Mall Zepbound support location

Bronx

Bartow Mall

2063A Bartow Ave, Bronx, NY 10475

A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.

View weight-loss location Get directions
Crown Heights Zepbound support location

Brooklyn

Crown Heights

341 Eastern Pkwy, Brooklyn, NY 11216

A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.

View weight-loss location Get directions
Hicksville Zepbound support location

Long Island

Hicksville

232 W Old Country Rd, Hicksville, NY 11801

A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.

View weight-loss location Get directions
Jackson Heights Zepbound support location

Queens

Jackson Heights

80-10 Northern Blvd, Jackson Heights, NY 11372

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.

View weight-loss location Get directions
Jamaica Zepbound support location

Queens

Jamaica

90-18 Sutphin Blvd, Jamaica, NY 11435

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.

View weight-loss location Get directions
Long Island City Zepbound support location

Queens

Long Island City

30-07 36th Ave, Astoria, NY 11106

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.

View weight-loss location Get directions
Mineola Zepbound support location

Long Island

Mineola

135 Mineola Blvd, Mineola, NY 11501

A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.

View weight-loss location Get directions
StuyTown Zepbound support location

Manhattan

StuyTown

259 1st Ave, New York, NY 10003

A Manhattan access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.

View weight-loss location Get directions
Williamsburg Zepbound support location

Brooklyn

Williamsburg

308 Graham Ave, Brooklyn, NY 11211

A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.

View weight-loss location Get directions

What usually slows a Zepbound start down

Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Zepbound prescription coverage is separate from visit coverage and often depends on obesity-drug exclusions, prior authorization rules, employer carve-outs, and the pharmacy benefit.

Zepbound self-pay is usually a workflow, not just a price. It starts with the visit, medical review, and prescription, then moves into dose selection, pharmacy channel, program eligibility, refill timing, and follow-up. Some self-pay programs depend on staying inside refill windows, so operational planning matters.

The FDA resolved the national tirzepatide shortage in October 2024, but patients can still run into localized supply disruptions as product moves through wholesalers, pharmacies, and dose-specific refill queues. Prior authorization timing, refill gaps, and whether the prescription is filled through a retail or direct channel can all change whether the medication is actually available when the patient needs it.

Related GLP-1 options already available live

main weight-loss overview

Use the current weight-loss overview when the patient still needs the broad parent guidance for booking flow, locations, and overall program context.

Tirzepatide in NYC

Use tirzepatide guidance for broader medication questions beyond brand-specific access.

Wegovy in NYC

Use Wegovy guidance when semaglutide may be a better fit than tirzepatide.

Wegovy follow-up

Use the Wegovy follow-up guidance when the patient already started semaglutide and the real need is ongoing titration and refill support.

Questions about Zepbound

Zepbound is reviewed as part of chronic weight-management care for eligible adults, usually alongside diet, activity, and structured provider follow-up rather than as a one-time prescription.
Zepbound is reviewed for adults with obesity, or adults with overweight plus at least one weight-related medical condition, alongside a reduced-calorie diet and increased physical activity. FDA also approved Zepbound for some adults with moderate to severe obstructive sleep apnea and obesity. The actual decision still depends on medical history, GI tolerance, current medications, thyroid-cancer risk factors, pregnancy planning, and whether another GLP-1 path fits better.
Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Zepbound prescription coverage is separate from visit coverage and often depends on obesity-drug exclusions, prior authorization rules, employer carve-outs, and the pharmacy benefit.
Zepbound self-pay is usually a workflow, not just a price. It starts with the visit, medical review, and prescription, then moves into dose selection, pharmacy channel, program eligibility, refill timing, and follow-up. Some self-pay programs depend on staying inside refill windows, so operational planning matters.
The FDA resolved the national tirzepatide shortage in October 2024, but patients can still run into localized supply disruptions as product moves through wholesalers, pharmacies, and dose-specific refill queues. Prior authorization timing, refill gaps, and whether the prescription is filled through a retail or direct channel can all change whether the medication is actually available when the patient needs it.
Zepbound and Wegovy are both once-weekly branded obesity medications, but Zepbound uses tirzepatide (GIP plus GLP-1) while Wegovy uses semaglutide (GLP-1 only). Lilly's SURMOUNT-5 results showed higher average weight loss with Zepbound than Wegovy at 72 weeks, but the better fit still depends on coverage, tolerability, refill stability, and whether the patient is already doing well on Wegovy.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

This answered the Zepbound-specific questions I actually had before booking.

Verified Patient
(4.9)

Helpful that insurance, self-pay, and availability were separated instead of being mashed into one generic details.

Verified Patient
(4.9)

The location details made it easier to move from research into a real visit.

Verified Patient
(4.9)

This felt much more practical than most NYC Zepbound options because it covered refill and pharmacy issues too.

Verified Patient
(4.9)

The comparison section made it clearer when Zepbound fits better than Wegovy and when it does not.

Nao medical

Start with the Zepbound question that matters most

Use insurance for prior-authorization questions, self-pay workflow when coverage is the blocker, availability when fulfillment is unstable, and the comparison guide when the real decision is Zepbound versus Wegovy.

Review Zepbound insurance details